🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
RBC Bioscience Corporation (TPEX:6848)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.60
-1.45 (-7.23%)
Nov 20, 2026, 1:48 PM CST

RBC Bioscience Statistics

Total Valuation

RBC Bioscience has a market cap or net worth of TWD 265.49 million. The enterprise value is 639.06 million.

Market Cap265.49M
Enterprise Value 639.06M

Important Dates

The next estimated earnings date is Wednesday, April 21, 2027.

Earnings Date Apr 21, 2027
Ex-Dividend Date Sep 2, 2026

Share Statistics

RBC Bioscience has 14.27 million shares outstanding. The number of shares has decreased by -0.06% in one year.

Current Share Class 14.27M
Shares Outstanding 14.27M
Shares Change (YoY) -0.06%
Shares Change (QoQ) -0.41%
Owned by Insiders (%) 29.02%
Owned by Institutions (%) n/a
Float 8.08M

Valuation Ratios

The trailing PE ratio is 17.43.

PE Ratio 17.43
Forward PE n/a
PS Ratio 1.27
PB Ratio 1.27
P/TBV Ratio 1.37
P/FCF Ratio 6.26
P/OCF Ratio 6.11
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.48, with an EV/FCF ratio of 15.07.

EV / Earnings 41.73
EV / Sales 3.05
EV / EBITDA 17.48
EV / EBIT 30.93
EV / FCF 15.07

Financial Position

The company has a current ratio of 0.71, with a Debt / Equity ratio of 1.89.

Current Ratio 0.71
Quick Ratio 0.31
Debt / Equity 1.89
Debt / EBITDA 10.81
Debt / FCF 9.32
Interest Coverage 2.31

Financial Efficiency

Return on equity (ROE) is 6.41% and return on invested capital (ROIC) is 2.72%.

Return on Equity (ROE) 6.41%
Return on Assets (ROA) 2.14%
Return on Invested Capital (ROIC) 2.72%
Return on Capital Employed (ROCE) 3.79%
Weighted Average Cost of Capital (WACC) 3.76%
Revenue Per Employee 4.19M
Profits Per Employee 306,260
Employee Count50
Asset Turnover 0.29
Inventory Turnover 2.15

Taxes

In the past 12 months, RBC Bioscience has paid 3.96 million in taxes.

Income Tax 3.96M
Effective Tax Rate 20.54%

Stock Price Statistics

The stock price has increased by +9.41% in the last 52 weeks. The beta is 0.44, so RBC Bioscience's price volatility has been lower than the market average.

Beta (5Y) 0.44
52-Week Price Change +9.41%
50-Day Moving Average 20.92
200-Day Moving Average 19.49
Relative Strength Index (RSI) 26.90
Average Volume (20 Days) 13,092

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RBC Bioscience had revenue of TWD 209.59 million and earned 15.31 million in profits. Earnings per share was 1.07.

Revenue209.59M
Gross Profit 99.34M
Operating Income 20.66M
Pretax Income 19.27M
Net Income 15.31M
EBITDA 35.34M
EBIT 20.66M
Earnings Per Share (EPS) 1.07
Full Income Statement

Balance Sheet

The company has 21.67 million in cash and 395.23 million in debt, with a net cash position of -373.57 million or -26.17 per share.

Cash & Cash Equivalents 21.67M
Total Debt 395.23M
Net Cash -373.57M
Net Cash Per Share -26.17
Equity (Book Value) 209.16M
Book Value Per Share 13.07
Working Capital -46.88M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 43.43 million and capital expenditures -1.04 million, giving a free cash flow of 42.40 million.

Operating Cash Flow 43.43M
Capital Expenditures -1.04M
Depreciation & Amortization 14.68M
Net Borrowing -3.94M
Free Cash Flow 42.40M
FCF Per Share 2.97
Full Cash Flow Statement

Margins

Gross margin is 47.40%, with operating and profit margins of 9.86% and 7.31%.

Gross Margin 47.40%
Operating Margin 9.86%
Pretax Margin 9.19%
Profit Margin 7.31%
EBITDA Margin 16.86%
EBIT Margin 9.86%
FCF Margin 20.23%

Dividends & Yields

This stock pays an annual dividend of 3.53, which amounts to a dividend yield of 19.00%.

Dividend Per Share 3.53
Dividend Yield 19.00%
Dividend Growth (YoY) 1,478.20%
Years of Dividend Growth n/a
Payout Ratio 469.27%
FCF Payout Ratio 159.39%
Buyback Yield 0.06%
Shareholder Yield 19.07%
Earnings Yield 5.74%
FCF Yield 15.97%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on August 11, 2025. It was a forward split with a ratio of 1.1.

Last Split Date Aug 11, 2025
Split Type Forward
Split Ratio 1.1

Scores

Altman Z-Score n/a
Piotroski F-Score 7